Skip to main content
Roisin O'Cearbhaill, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

RoisinEilishO'CearbhaillMDMB BCh BAO, MRCPI, MRPUK

Oncology New York, NY

Associate Professor, Medicine, Weill Cornell Medical College

Overview of Dr. O'Cearbhaill

Dr. Roisin O'Cearbhaill is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from National University of Ireland, Galway and has been in practice 15 years. Dr. O'Cearbhaill accepts several types of health insurance, listed below. She is one of 467 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She also speaks multiple languages, including French and Spanish. She has more than 70 publications and over 500 citings.

Education & Training

  • National University of Ireland, Galway
    National University of Ireland, GalwayClass of 2002

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2020 - 2025
  • NY State Medical License
    NY State Medical License 2010 - 2025
  • CT State Medical License
    CT State Medical License 2023 - 2024
  • European Society for Medical OncologyMedical Oncology
  • Royal College of Physicians, IrelandInternal Medicine

Awards, Honors, & Recognition

  • Excellence in Teaching Award. Clinical Preceptor Weill Cornell Medical College, 2017
  • Career Development Award Conquer Cancer Foundation, ASCO, 2013
  • Young Investigator Award Kaleidoscope of Hope, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Phase 1 Dose-Escalation Study of Intraperitoneal Cisplatin, intravenous/intraperitoneal Paclitaxel, Bevacizumab, and Olaparib for Newly Diagnosed Ovarian Cancer  
    Karen A Cadoo, Roisin E O'Cearbhaill, Dmitriy Zamarin, Paul J Sabbatini, William P Tew, Carol Aghajanian, Jason A Konner, Gynecologic Oncology
  • Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)  
    Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology

Press Mentions

  • The Power of Shared Purpose: Transforming Gynecologic Cancer Care
    The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
  • Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer
    Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian CancerNovember 11th, 2023

Committees

  • Vice chair, Clinical Practice Committee, Society of Gynecologic Oncology
  • Chair, Developmental Therapeutics; Member of Medical Oncology and Immunology Committees, NRG Oncology

Professional Memberships

Other Languages

  • French, Spanish

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Tennessee Network 5
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Humana/ChoiceCare+ Network PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment